Vir Biotechnology

San Francisco, United States

Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.

Feb 2026

Post-IPO Equity

Biotechnology Health Care Medical Therapeutics

Top Investors

ARCH Venture Partners8VCBill & Melinda Gates FoundationSoftBank Vision FundGoogle Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Vir Biotechnology

Who are Vir Biotechnology's investors?

Vir Biotechnology's investors include ARCH Venture Partners, 8VC, Bill & Melinda Gates Foundation, SoftBank Vision Fund, Google Ventures.

Where is Vir Biotechnology headquartered?

Vir Biotechnology is headquartered in San Francisco, United States.

What does Vir Biotechnology do?

Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.

What stage is Vir Biotechnology at?

Vir Biotechnology is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 25, 2026.

MLA

"Vir Biotechnology — Funding & Investors." VCBacked, February 25, 2026, https://www.vcbacked.co/company/vir-biotechnology. Accessed July 1, 2026.

APA

VCBacked. (2026). Vir Biotechnology — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/vir-biotechnology

Wikipedia (cite web)

{{cite web |title=Vir Biotechnology — Funding & Investors |url=https://www.vcbacked.co/company/vir-biotechnology |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 25, 2026.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.